DK1163007T3 - TRIS-holdige propofol-formuleringer - Google Patents
TRIS-holdige propofol-formuleringerInfo
- Publication number
- DK1163007T3 DK1163007T3 DK00918250T DK00918250T DK1163007T3 DK 1163007 T3 DK1163007 T3 DK 1163007T3 DK 00918250 T DK00918250 T DK 00918250T DK 00918250 T DK00918250 T DK 00918250T DK 1163007 T3 DK1163007 T3 DK 1163007T3
- Authority
- DK
- Denmark
- Prior art keywords
- tris
- containing propofol
- propofol formulations
- signficant
- tromethamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/275,145 US6177477B1 (en) | 1999-03-24 | 1999-03-24 | Propofol formulation containing TRIS |
PCT/US2000/007598 WO2000056364A1 (en) | 1999-03-24 | 2000-03-23 | Propofol formulation containing tris |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1163007T3 true DK1163007T3 (da) | 2003-04-22 |
Family
ID=23051046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00918250T DK1163007T3 (da) | 1999-03-24 | 2000-03-23 | TRIS-holdige propofol-formuleringer |
Country Status (10)
Country | Link |
---|---|
US (1) | US6177477B1 (da) |
EP (1) | EP1163007B1 (da) |
AT (1) | ATE231003T1 (da) |
AU (1) | AU3909400A (da) |
BR (1) | BR0009286A (da) |
CA (1) | CA2367093A1 (da) |
DE (1) | DE60001223T2 (da) |
DK (1) | DK1163007T3 (da) |
ES (1) | ES2189750T3 (da) |
WO (1) | WO2000056364A1 (da) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
JP4198318B2 (ja) * | 1998-08-19 | 2008-12-17 | ヤーゴテック アクチェンゲゼルシャフト | プロポフォールの注射可能水性分散物 |
US6726919B2 (en) | 2000-06-16 | 2004-04-27 | Rtp Pharma, Inc. | Injectable dispersion of propofol |
US20030054042A1 (en) * | 2001-09-14 | 2003-03-20 | Elaine Liversidge | Stabilization of chemical compounds using nanoparticulate formulations |
JP2005517679A (ja) * | 2001-12-28 | 2005-06-16 | ギルフォード ファーマシューティカルズ インコーポレイテッド | プロポフォールの水溶性プロドラッグの水ベースの薬学的製剤 |
IL162862A0 (en) * | 2002-01-25 | 2005-11-20 | Theravance Inc | Short-acting sedative hypnotic agents for anesthesia and sedation |
US20080220075A1 (en) * | 2002-03-20 | 2008-09-11 | Elan Pharma International Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
DE60309300T3 (de) * | 2002-03-20 | 2011-02-24 | Elan Pharma International Ltd. | Nanopartikelzusammensetzungen von angiogeneseinhibitoren |
KR100459025B1 (ko) * | 2002-05-02 | 2004-12-03 | (주) 에프디엘 | 프로포폴을 함유하는 신규한 주사제용 조성물 |
AU2003222491A1 (en) * | 2002-05-02 | 2003-12-31 | Fdl, Inc. | Novel parenteral composition comprising propofol |
CN1708270A (zh) * | 2002-10-29 | 2005-12-14 | 转化医药公司 | 丙泊酚与半胱氨酸 |
TR200502189T1 (tr) * | 2002-12-09 | 2007-01-22 | American Bioscience, Inc. | Kompozisyonlar ve farmakolojik etken maddelerin aktarımı için yöntemler. |
US20040225022A1 (en) * | 2003-05-09 | 2004-11-11 | Desai Neil P. | Propofol formulation containing reduced oil and surfactants |
US8476010B2 (en) | 2003-07-10 | 2013-07-02 | App Pharmaceuticals Llc | Propofol formulations with non-reactive container closures |
DE602004023509D1 (de) * | 2003-07-23 | 2009-11-19 | Theravance Inc | Pharmazeutische zusammensetzungen eines kurzwirkenden sedativen hypnosemittels |
US8546453B2 (en) * | 2003-08-14 | 2013-10-01 | Rensheng Zhang | Propofol compositions and methods for reducing pain associated with propofol injection |
US20070293586A1 (en) * | 2005-02-03 | 2007-12-20 | Suresh Dixit | Novel propofol composition comprising ascorbic acid or pharmaceutically acceptable salts thereof |
CN100358513C (zh) * | 2005-04-07 | 2008-01-02 | 常州市第四制药厂有限公司 | 一种丙泊酚注射液的制备工艺 |
US20090131538A1 (en) * | 2005-05-27 | 2009-05-21 | Taro Pharmaceuticals North America, Inc. c/o Taro Pharmaceuticals U.S.A., Inc. | Novel propofol composition comprising a pharmaceutically acceptable salt of formaldehyde sulfoxylate |
CN101291658B (zh) * | 2005-08-31 | 2014-04-16 | 阿布拉科斯生物科学有限公司 | 用于制备稳定性增加的水难溶性药物的组合物和方法 |
TWI417114B (zh) | 2005-08-31 | 2013-12-01 | Abraxis Bioscience Llc | 具有增強穩定性之弱水溶性藥物之組合物及其製備方法 |
WO2010082092A1 (en) | 2009-01-13 | 2010-07-22 | Claris Lifesciences Limited | Propofol based anesthetic with preservative |
CN102869345B (zh) | 2010-03-17 | 2015-02-11 | 诺瓦利克有限责任公司 | 用于治疗眼内压增高的药物组合物 |
EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
EP2462921A1 (en) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
PL2661280T3 (pl) * | 2011-01-04 | 2019-05-31 | Novaliq Gmbh | Emulsje typu olej w wodzie zawierające semifluorowane alkany |
CA2834862C (en) | 2011-05-25 | 2019-12-17 | Novaliq Gmbh | Pharmaceutical composition for administration to nails |
PL3192501T3 (pl) | 2011-05-25 | 2020-11-02 | Novaliq Gmbh | Kompozycja farmaceutyczna do miejscowego stosowania oparta na semifluorowanych alkanach |
KR101989648B1 (ko) | 2012-01-23 | 2019-06-14 | 노바리크 게엠베하 | 부분불소화 알칸에 기초한 안정화된 단백질 조성물 |
WO2013172999A1 (en) | 2012-05-16 | 2013-11-21 | Mewa Singh | Pharmaceutical compositions for the delivery of substantially water-insoluble drugs |
EP2884964A4 (en) * | 2012-08-16 | 2016-01-06 | Emcure Pharmaceuticals Ltd | PHARMACEUTICAL COMPOSITION OF PROPOFOL |
ES2965828T3 (es) | 2012-09-12 | 2024-04-17 | Novaliq Gmbh | Composiciones de alcano semifluorado |
CA2883002C (en) | 2012-09-12 | 2019-05-21 | Novaliq Gmbh | Compositions comprising mixtures of semifluorinated alkanes |
US10273298B2 (en) | 2013-07-23 | 2019-04-30 | Novaliq Gmbh | Stabilized antibody compositions |
WO2015054448A1 (en) * | 2013-10-11 | 2015-04-16 | University Of Florida Research Foundation, Inc. | Method of manufacturing stable emulsions and compositions containing the same |
JP6392883B2 (ja) * | 2014-09-25 | 2018-09-19 | 富士フイルム株式会社 | プロポフォール含有水中油型エマルション組成物及びその製造方法 |
WO2017017693A1 (en) | 2015-07-24 | 2017-02-02 | Neon Laboratories Limited | Stabilized injectable emulsion of propofol and ketamine |
US11622937B2 (en) | 2015-08-20 | 2023-04-11 | Mewa Singh | Polyphenolic polymer to make water-insoluble molecules become water-soluble |
CN110403923B (zh) | 2015-09-30 | 2021-09-21 | 诺瓦利克有限责任公司 | 半氟化化合物和其组合物 |
EP3722274B1 (en) | 2015-09-30 | 2023-06-07 | Novaliq GmbH | 2-perfluorobutyl pentane for ophthalmic administration |
DK3442480T3 (da) | 2016-06-23 | 2020-01-13 | Novaliq Gmbh | Fremgangsmåde til topisk indgivelse |
ES2969758T3 (es) | 2016-09-22 | 2024-05-22 | Novaliq Gmbh | Composiciones farmacéuticas para usar en la terapia de la blefaritis |
CN109906085B (zh) | 2016-09-23 | 2024-03-08 | 诺瓦利克有限责任公司 | 含有环孢素的眼用组合物 |
AU2018253944B2 (en) | 2017-04-21 | 2022-09-15 | Dermaliq Therapeutics, Inc. | Iodine compositions |
EP3621601A1 (en) | 2017-05-12 | 2020-03-18 | Novaliq GmbH | Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions |
US11723861B2 (en) | 2017-09-27 | 2023-08-15 | Novaliq Gmbh | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |
US11896559B2 (en) | 2017-10-04 | 2024-02-13 | Novaliq Gmbh | Opthalmic compositions comprising F6H8 |
SG11202007858VA (en) | 2018-03-02 | 2020-09-29 | Novaliq Gmbh | Pharmaceutical compositions comprising nebivolol |
SG11202102820VA (en) | 2018-10-12 | 2021-04-29 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1472793A (en) * | 1974-03-28 | 1977-05-04 | Ici Ltd | Pharmaceutical compositions |
US4060639A (en) * | 1976-05-14 | 1977-11-29 | Merck & Co., Inc. | Broad spectrum antibacterial compositions containing tris-(hydroxymethyl)-aminoethane and dicycloaliphatic-alkyl polyamines |
DE4028957C2 (de) * | 1990-09-12 | 1994-05-11 | Oliver Bock | Therapeutikum für den Mundbereich |
US5504113A (en) * | 1994-03-02 | 1996-04-02 | Allergan, Inc. | Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug |
GB9405593D0 (en) * | 1994-03-22 | 1994-05-11 | Zeneca Ltd | Pharmaceutical compositions |
US5633240A (en) * | 1994-09-01 | 1997-05-27 | Academic Pharmaceuticals | Parenteral solutions containing metolazone |
US5637625A (en) * | 1996-03-19 | 1997-06-10 | Research Triangle Pharmaceuticals Ltd. | Propofol microdroplet formulations |
CH692322A5 (it) * | 1997-05-26 | 2002-05-15 | Westy Ag | Formulazione iniettabile limpida di Propofol. |
US5962536A (en) * | 1998-07-31 | 1999-10-05 | Komer; Gene | Injectable propofol formulations |
US6028108A (en) * | 1998-10-22 | 2000-02-22 | America Home Products Corporation | Propofol composition comprising pentetate |
-
1999
- 1999-03-24 US US09/275,145 patent/US6177477B1/en not_active Expired - Fee Related
-
2000
- 2000-03-23 AT AT00918250T patent/ATE231003T1/de not_active IP Right Cessation
- 2000-03-23 CA CA002367093A patent/CA2367093A1/en not_active Abandoned
- 2000-03-23 BR BR0009286-0A patent/BR0009286A/pt not_active IP Right Cessation
- 2000-03-23 ES ES00918250T patent/ES2189750T3/es not_active Expired - Lifetime
- 2000-03-23 EP EP00918250A patent/EP1163007B1/en not_active Expired - Lifetime
- 2000-03-23 WO PCT/US2000/007598 patent/WO2000056364A1/en active IP Right Grant
- 2000-03-23 DE DE60001223T patent/DE60001223T2/de not_active Expired - Fee Related
- 2000-03-23 AU AU39094/00A patent/AU3909400A/en not_active Abandoned
- 2000-03-23 DK DK00918250T patent/DK1163007T3/da active
Also Published As
Publication number | Publication date |
---|---|
BR0009286A (pt) | 2002-01-22 |
EP1163007A1 (en) | 2001-12-19 |
AU3909400A (en) | 2000-10-09 |
WO2000056364A1 (en) | 2000-09-28 |
DE60001223D1 (de) | 2003-02-20 |
DE60001223T2 (de) | 2004-01-22 |
CA2367093A1 (en) | 2000-09-28 |
US6177477B1 (en) | 2001-01-23 |
EP1163007B1 (en) | 2003-01-15 |
ES2189750T3 (es) | 2003-07-16 |
ATE231003T1 (de) | 2003-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1163007T3 (da) | TRIS-holdige propofol-formuleringer | |
DE69924133D1 (de) | Diethylentriaminpentaessigsäure enthaltende propofol-zusammensetzung | |
CA2319810A1 (en) | Propofol composition containing sulfite | |
EP1238677A3 (en) | Parenteral fat emulsions comprising edetate as preservative | |
MXPA02008097A (es) | Formulacion de propol con inhibicion microbiana mejorada. | |
MY125921A (en) | Compositions containing organic compounds | |
WO1998058629A3 (en) | Preparation of pharmaceutical compositions | |
SE7703592L (sv) | Anthelmintikum | |
ATE427925T1 (de) | Phenoxycarbonsaureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe | |
TR199801541A2 (xx) | N,N-Dietil-m-Toluamid'in (DEET) Anti-Parazit i�levi | |
FI964285A0 (fi) | Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet | |
KR910021375A (ko) | 4-(디-n-프로필)아미노-6-아미노카보닐-1,3,4,5-테트라하이드로벤즈[cd]인돌의 결정형 염 | |
ES2037742T3 (es) | Procedimiento de obtencion de una composicion para administracion intravenosa. | |
WO2004100935A3 (en) | Propofol formulation containing reduced oil and surfactants | |
BRPI9916820B8 (pt) | composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método | |
SE9403389D0 (sv) | Pharmaceutical composition containing derivattves of sex hormones | |
NZ220800A (en) | Tetrahydrobenzothiazoles and pharmaceutical compositions | |
ATE90095T1 (de) | Optisch aktive produkte von 20,21dinoreburnamenin-derivaten,verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen. | |
AU5284999A (en) | New injectable formulations containing ramoplanin | |
ES2171749T3 (es) | Composiciones farmaceuticas que contienen inhibidores de la agregacion de plaquetas. | |
AR004223A1 (es) | Composiciones para inhibir la agregacion de plaquetas y el uso de las mismas en la manufactura de un medicamento. | |
BG96101A (bg) | Авермектинови производни, по-специално с-076 съединения,и метод за получаването им |